Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Breast cancer

Implementation of BRCA Test among Young Breast Cancer Patients in South Korea: A Nationwide Cohort Study

Yung-Huyn Hwang, Tae-Kyung Yoo, Sae Byul Lee, Jisun Kim, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Il Yong Chung

Cancer Res Treat. 2024;56(3):802-808. Published online February 19, 2024 DOI: https://doi.org/10.4143/crt.2023.1186

Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study

Ruyan Zhang, Xiaoran Liu, Guohong Song, Yan Zhang, Huiping Li

Cancer Res Treat. 2024;56(3):795-801. Published online December 20, 2023 DOI: https://doi.org/10.4143/crt.2023.1151

HER2-Low Breast Cancer: Now and in the Future

Sora Kang, Sung-Bae Kim

Cancer Res Treat. 2024;56(3):700-720. Published online January 30, 2024 DOI: https://doi.org/10.4143/crt.2023.1138

Breast cancer

PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance

Eun Kyung Han, Ji Won Woo, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park

Cancer Res Treat. 2024;56(2):557-566. Published online December 12, 2023 DOI: https://doi.org/10.4143/crt.2023.1025

Assessment of Eligibility and Utilization of Accelerated Partial Breast Irradiation in Korean Breast Cancer Patients (KROG 22-15)

Seok-Joo Chun, Ji Hwan Jo, Yong Bae Kim, Sangjoon Park, Sung-Ja Ahn, Su Ssan Kim, Kyubo Kim, Kyung Hwan Shin

Cancer Res Treat. 2024;56(2):549-556. Published online December 8, 2023 DOI: https://doi.org/10.4143/crt.2023.1109

Genomic Characteristics and Its Therapeutic Implications in Breast Cancer Patients with Detectable Molecular Residual Disease

Shu Zhang, Yan Jiang, Lu Zhou, Jing Xu, Gang Zhang, Lu Shen, Yan Xu

Cancer Res Treat. 2024;56(2):538-548. Published online December 5, 2023 DOI: https://doi.org/10.4143/crt.2023.1059

Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study

Tae Hoon Lee, Haeyoung Kim, Yeon Jeong Kim, Woong-Yang Park, Won Park, Won Kyung Cho, Nalee Kim

Cancer Res Treat. 2024;56(2):531-537. Published online November 10, 2023 DOI: https://doi.org/10.4143/crt.2023.996

Web of Science 1

Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer

Thi Xuan Mai Tran, Soyeoun Kim, Chihwan Cha, Boyoung Park

Cancer Res Treat. 2024;56(2):522-530. Published online October 30, 2023 DOI: https://doi.org/10.4143/crt.2023.729

Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study

Kuikui Jiang, Ruoxi Hong, Wen Xia, Qianyi Lu, Liang Li, Jianhao Huang, Yanxia Shi, Zhongyu Yuan, Qiufan Zheng, Xin An, Cong Xue, Jiajia Huang, Xiwen Bi, Meiting Chen, Jingmin Zhang, Fei Xu, Shusen Wang

Cancer Res Treat. 2024;56(2):513-521. Published online October 12, 2023 DOI: https://doi.org/10.4143/crt.2023.786

Web of Science 1 Crossref 1

Changes in Invasive Breast Carcinomas after Neoadjuvant Chemotherapy Can Influence Adjuvant Therapeutic Decisions

Bárbara Jaime dos Santos, Débora Balabram, Virginia Mara Reis Gomes, Carolina Costa Café de Castro, Paulo Henrique Costa Diniz, Marcelo Araújo Buzelin, Cristiana Buzelin Nunes

Cancer Res Treat. 2024;56(1):178-190. Published online August 1, 2023 DOI: https://doi.org/10.4143/crt.2023.386

Tumor Microenvironment Can Predict Chemotherapy Response of Patients with Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Dongjin Kim, Yeuni Yu, Ki Sun Jung, Yun Hak Kim, Jae-Joon Kim

Cancer Res Treat. 2024;56(1):162-177. Published online July 24, 2023 DOI: https://doi.org/10.4143/crt.2023.330

Web of Science 1 Crossref 1

Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine

Hyunwoo Lee, Yoon Ah Cho, Deok Geun Kim, Eun Yoon Cho

Cancer Res Treat. 2024;56(1):149-161. Published online August 11, 2023 DOI: https://doi.org/10.4143/crt.2023.800

Web of Science 4 Crossref 4

Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in BRCA Mutation Carriers: A Nationwide Study in South Korea

Hye Yeon Kim, Jisoo Park, Seok Joo Moon, Sohyeon Jeong, Jin Hwa Hong, Jae Kwan Lee, Geum Joon Cho, Hyun-Woong Cho

Cancer Res Treat. 2024;56(1):143-148. Published online August 16, 2023 DOI: https://doi.org/10.4143/crt.2023.653

Web of Science 1 Crossref 1

Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes

Xin Li, Zehao Li, Lin Li, Tong Liu, Cheng Qian, Yanlv Ren, Zhigao Li, Kejin Chen, Dongchen Ji, Ming Zhang, Jinsong Wang

Cancer Res Treat. 2024;56(1):134-142. Published online August 14, 2023 DOI: https://doi.org/10.4143/crt.2023.652

Web of Science 1 Crossref 1

Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study

Danbee Kang, Seri Park, Hyo Jung Kim, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Ji-Yeon Kim, Seok Jin Nam, Juhee Cho, Yeon Hee Park

Cancer Res Treat. 2024;56(1):125-133. Published online September 4, 2023 DOI: https://doi.org/10.4143/crt.2023.673

Health-Seeking Behavior Returning to Normalcy Overcoming COVID-19 Threat in Breast Cancer

Eun-Gyeong Lee, Yireh Han, Dong-Eun Lee, Hyeong-Gon Moon, Hyoung Won Koh, Eun-Kyu Kim, So-Youn Jung

Cancer Res Treat. 2023;55(4):1222-1230. Published online April 3, 2023 DOI: https://doi.org/10.4143/crt.2023.364

Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy

Youzhao Ma, Mingda Zhu, Jingyang Zhang, Minhao Lv, Xiuchun Chen, Zhenzhen Liu

Cancer Res Treat. 2023;55(4):1210-1221. Published online April 4, 2023 DOI: https://doi.org/10.4143/crt.2022.1633

Web of Science 6 Crossref 7

Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor–Positive Metastatic Breast Cancer

Seul-Gi Kim, Min Hwan Kim, Sejung Park, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Byeong Woo Park, Seung Il Kim, Jung Hwan Ji, Joon Jeong, Kabsoo Shin, Jieun Lee, Hyung-Don Kim, Kyung Hae Jung, Joohyuk Sohn

Cancer Res Treat. 2023;55(4):1198-1209. Published online April 11, 2023 DOI: https://doi.org/10.4143/crt.2022.1543

Crossref 1

General

Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients

Wonyoung Choi, Yun-Hee Kim, Sang Myung Woo, Yebeen Yu, Mi Rim Lee, Woo Jin Lee, Jung Won Chun, Sung Hoon Sim, Heejung Chae, Hyoeun Shim, Keun Seok Lee, Sun-Young Kong

Cancer Res Treat. 2023;55(4):1077-1086. Published online June 12, 2023 DOI: https://doi.org/10.4143/crt.2022.1630

Web of Science 3 Crossref 4

Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer

Eunice Yoojin Lee, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im

Cancer Res Treat. 2023;55(4):1065-1076. Published online October 5, 2023 DOI: https://doi.org/10.4143/crt.2023.846

Web of Science 1 Crossref 1

Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA

Jung-Ki Yoon, Jongseong Ahn, Sheehyun Kim, Hwang-Phil Kim, Jun-kyu Kang, Duhee Bang, Yoojoo Lim, Tae-You Kim

Cancer Res Treat. 2023;55(3):1048-1052. Published online January 31, 2023 DOI: https://doi.org/10.4143/crt.2022.1529

Web of Science 2 Crossref 3

Breast cancer

Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies

Yong Wha Moon, Seung Ki Kim, Keun Seok Lee, Moon Hee Lee, Yeon Hee Park, Kyong Hwa Park, Gun Min Kim, Seungtaek Lim, Seung Ah Lee, Jae Duk Choi, Eunhye Baek, Hyesun Han, Seungjae Baek, Seock-Ah Im

Cancer Res Treat. 2023;55(3):766-777. Published online January 19, 2023 DOI: https://doi.org/10.4143/crt.2022.987

Crossref 1

Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy

Dowook Kim, Jin Ho Kim, In Ah Kim, Ji Hyun Chang, Kyung Hwan Shin

Cancer Res Treat. 2023;55(2):592-602. Published online October 11, 2022 DOI: https://doi.org/10.4143/crt.2022.998

Web of Science 5 Crossref 4

Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population–Based Study by the SMARTSHIP Group

Haeyoung Kim, Su SSan Kim, Ji Sung Lee, Jae Sun Yoon, Hyun Jo Youn, Hyukjai Shin, Jeong Eon Lee, Se Kyung Lee, Il Yong Chung, So-Youn Jung, Young Jin Choi, Jihyoung Cho, Sang Uk Woo, Korean Breast Cancer Society

Cancer Res Treat. 2023;55(2):580-591. Published online December 27, 2022 DOI: https://doi.org/10.4143/crt.2022.410

Web of Science 1 Crossref 1

Quality Assessment and Trend for Breast Cancer Treatment Practice across South Korea Based on Nationwide Analysis of Korean Health Insurance Data during 2013-2017

Kyu Hye Choi, Soo-Yoon Sung, Sea-Won Lee, Ye Won Jeon, Sung Hwan Kim, Jong Hoon Lee

Cancer Res Treat. 2023;55(2):570-579. Published online December 5, 2022 DOI: https://doi.org/10.4143/crt.2022.882

Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis

Changjin Lim, Eunhye Kang, Ji Gwang Jung, Jong-Ho Cheun, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han

Cancer Res Treat. 2023;55(2):562-569. Published online September 26, 2022 DOI: https://doi.org/10.4143/crt.2022.871

Marked Reduction in the Risk of Dementia in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study

Jooyoung Oh, Hye Sun Lee, Soyoung Jeon, Jeong-Ho Seok, Tae-Kyung Yoo, Woo-Chan Park, Chang Ik Yoon

Cancer Res Treat. 2023;55(2):551-561. Published online October 19, 2022 DOI: https://doi.org/10.4143/crt.2022.272

Web of Science 1 Crossref 1

Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy

Eun-Gyeong Lee, Dong-Eun Lee, Hyun hee Kim, Jai Hong Han, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Heejung Chae, Sung Hoon Sim, Keun Seok Lee, Youngmee Kwon, So-Youn Jung

Cancer Res Treat. 2023;55(2):542-550. Published online September 8, 2022 DOI: https://doi.org/10.4143/crt.2022.834

Web of Science 5 Crossref 5

PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients

Ju Won Kim, Ah Reum Lim, Ji Young You, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park

Cancer Res Treat. 2023;55(2):531-541. Published online September 7, 2022 DOI: https://doi.org/10.4143/crt.2022.221

Web of Science 6 Crossref 9

A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)

Dae-Won Lee, Bhumsuk Keam, Keun Seok Lee, Jin-Hee Ahn, Joohyuk Sohn, Jin Seok Ahn, Moon Hee Lee, Jee Hyun Kim, Kyung Eun Lee, Hyo Jung Kim, Si-Young Kim, Yeon Hee Park, Chan-Young Ock, Kyung-Hun Lee, Sae-Won Han, Sung-Bae Kim, Young Hyuck Im, Hyun Cheol Chung, Do-Youn Oh, Seock-Ah Im

Cancer Res Treat. 2023;55(2):523-530. Published online November 8, 2022 DOI: https://doi.org/10.4143/crt.2022.1360

Web of Science 2 Crossref 2